Robbins Geller Rudman & Dowd LLP Investigates Potential Securities Violations by Morphic Holding, Inc.

Robbins Geller Rudman & Dowd LLP, a renowned law firm specializing in complex class action cases, is currently investigating potential violations of U.S. federal securities laws by Morphic Holding, Inc. The investigation focuses on whether Morphic and certain top executives made false or misleading statements and failed to disclose material information to investors.

Morphic Holding, Inc. is a biopharmaceutical company dedicated to developing oral integrin therapies for the treatment of chronic diseases such as autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

The investigation was prompted by the release of abstract data from Morphic’s EMERALD-1 Phase 2a trial for its MORF-057 drug on September 22, 2023. The data revealed that 25.7% of patients achieved endoscopic improvement. Following this announcement, the price of Morphic stock experienced a decline.

Robbins Geller Rudman & Dowd LLP is recognized for its expertise in securities fraud cases and has consistently secured substantial recoveries for investors. In fact, the firm was ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, having recovered over $1.75 billion for investors in 2022 alone. Over the past three years, Robbins Geller has recovered nearly $5.3 billion, more than any other plaintiffs’ firm.

Investors who have information relevant to this investigation or have suffered losses as Morphic investors are encouraged to provide their details through the provided link or contact attorney J.C. Sanchez via phone or email.

Please note that past results do not guarantee future outcomes, and services may be performed by attorneys in any of Robbins Geller Rudman & Dowd LLP’s offices.

For more information about the investigation and the firm’s services in securities fraud cases, please visit the provided links.

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, Suite 1900, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com